Real Life Study on Iron Isomaltoside 1000 in the Treatment of ID in CKD, Heart Failure, ObGyn, IBD, Cancer and Elective Surgery (Real-CHOICE).
Clinical trial NCT04318405 · COMPLETED
Trial details
- NCT number
- NCT04318405
- Sponsor
- Pierre Fabre Pharma AG
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-07-10
- Primary completion
- 2022-11-30
- Enrollment
- 327
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.